Lowe Brockenbrough & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.5M | Sell |
27,005
-256
| -0.9% | -$91.3K | 0.47% | 55 |
|
|
2025
Q4 | $8.92M | Buy |
27,261
+116
| +0.4% | +$36.8K | 0.44% | 62 |
|
|
2025
Q3 | $7.66M | Buy |
27,145
+750
| +3% | +$218K | 0.39% | 63 |
|
|
2025
Q2 | $7.37M | Buy |
26,395
+1,991
| +8% | +$564K | 0.41% | 63 |
|
|
2025
Q1 | $7.6M | Buy |
24,404
+80
| +0.3% | +$23.6K | 0.5% | 60 |
|
|
2024
Q4 | $6.34M | Sell |
24,324
-312
| -1% | -$92.6K | 0.41% | 66 |
|
|
2024
Q3 | $7.94M | Sell |
24,636
-9,395
| -28% | -$3.07M | 0.51% | 58 |
|
|
2024
Q2 | $10.6M | Sell |
34,031
-47
| -0.1% | -$13.8K | 0.71% | 42 |
|
|
2024
Q1 | $9.69M | Buy |
34,078
+9,033
| +36% | +$2.64M | 0.65% | 49 |
|
|
2023
Q4 | $7.21M | Sell |
25,045
-11,205
| -31% | -$3.05M | 0.56% | 55 |
|
|
2023
Q3 | $9.74M | Sell |
36,250
-137
| -0.4% | -$34.2K | 0.76% | 40 |
|
|
2023
Q2 | $8.08M | Buy |
36,387
+3,261
| +10% | +$757K | 0.61% | 54 |
|
|
2023
Q1 | $8.01M | Buy |
33,126
+1,956
| +6% | +$480K | 0.65% | 53 |
|
|
2022
Q4 | $8.19M | Sell |
31,170
-1,624
| -5% | -$435K | 0.71% | 49 |
|
|
2022
Q3 | $7.39M | Sell |
32,794
-1,419
| -4% | -$344K | 0.71% | 48 |
|
|
2022
Q2 | $8.32M | Sell |
34,213
-381
| -1% | -$93.4K | 0.73% | 42 |
|
|
2022
Q1 | $8.37M | Sell |
34,594
-765
| -2% | -$176K | 0.62% | 55 |
|
|
2021
Q4 | $7.96M | Buy |
35,359
+580
| +2% | +$122K | 0.58% | 57 |
|
|
2021
Q3 | $7.4M | Buy |
34,779
+3,090
| +10% | +$711K | 0.58% | 54 |
|
|
2021
Q2 | $7.72M | Buy |
31,689
+517
| +2% | +$127K | 0.7% | 46 |
|
|
2021
Q1 | $7.76M | Buy |
31,172
+425
| +1% | +$101K | 0.75% | 48 |
|
|
2020
Q4 | $7.07M | Buy |
30,747
+204
| +0.7% | +$47K | 0.77% | 46 |
|
|
2020
Q3 | $7.76M | Sell |
30,543
-337
| -1% | -$83.5K | 0.97% | 33 |
|
|
2020
Q2 | $7.28M | Sell |
30,880
-421
| -1% | -$96.1K | 0.98% | 33 |
|
|
2020
Q1 | $6.35M | Sell |
31,301
-369
| -1% | -$80.6K | 1.05% | 29 |
|
|
2019
Q4 | $7.63M | Buy |
31,670
+1,290
| +4% | +$284K | 0.95% | 37 |
|
|
2019
Q3 | $5.88M | Buy |
30,380
+155
| +0.5% | +$29.8K | 0.79% | 42 |
|
|
2019
Q2 | $5.57M | Buy |
30,225
+153
| +0.5% | +$27.4K | 0.76% | 47 |
|
|
2019
Q1 | $5.71M | Buy |
30,072
+69
| +0.2% | +$13.2K | 0.8% | 40 |
|
|
2018
Q4 | $5.84M | Sell |
30,003
-330
| -1% | -$64.4K | 0.95% | 36 |
|
|
2018
Q3 | $6.29M | Sell |
30,333
-150
| -0.5% | -$29.6K | 0.88% | 38 |
|
|
2018
Q2 | $5.63M | Buy |
30,483
+1,417
| +5% | +$251K | 0.83% | 41 |
|
|
2018
Q1 | $4.96M | Sell |
29,066
-305
| -1% | -$56K | 0.73% | 47 |
|
|
2017
Q4 | $5.11M | Sell |
29,371
-95
| -0.3% | -$16.8K | 0.73% | 45 |
|
|
2017
Q3 | $5.49M | Sell |
29,466
-50
| -0.2% | -$8.86K | 0.84% | 42 |
|
|
2017
Q2 | $5.08M | Buy |
29,516
+346
| +1% | +$56.3K | 0.8% | 46 |
|
|
2017
Q1 | $4.79M | Buy |
29,170
+127
| +0.4% | +$21.1K | 0.76% | 48 |
|
|
2016
Q4 | $4.25M | Sell |
29,043
-13,655
| -32% | -$2.06M | 0.71% | 52 |
|
|
2016
Q3 | $7.12M | Buy |
42,698
+181
| +0.4% | +$30.6K | 1.23% | 24 |
|
|
2016
Q2 | $6.47M | Buy |
42,517
+873
| +2% | +$136K | 1.13% | 29 |
|
|
2016
Q1 | $6.24M | Buy |
41,644
+770
| +2% | +$114K | 1.07% | 30 |
|
|
2015
Q4 | $6.63M | Sell |
40,874
-657
| -2% | -$103K | 1.13% | 27 |
|
|
2015
Q3 | $5.75M | Sell |
41,531
-220
| -0.5% | -$34.7K | 1% | 35 |
|
|
2015
Q2 | $6.41M | Sell |
41,751
-1,535
| -4% | -$246K | 1.03% | 33 |
|
|
2015
Q1 | $6.92M | Buy |
43,286
+2,655
| +7% | +$418K | 1.09% | 29 |
|
|
2014
Q4 | $6.47M | Sell |
40,631
-7,980
| -16% | -$1.24M | 1.03% | 36 |
|
|
2014
Q3 | $6.83M | Sell |
48,611
-178
| -0.4% | -$23.2K | 1.09% | 30 |
|
|
2014
Q2 | $5.78M | Buy |
48,789
+2,422
| +5% | +$280K | 0.92% | 43 |
|
|
2014
Q1 | $5.72M | Sell |
46,367
-1,045
| -2% | -$127K | 0.95% | 41 |
|
|
2013
Q4 | $5.41M | Sell |
47,412
-2,061
| -4% | -$234K | 0.89% | 47 |
|
|
2013
Q3 | $5.54M | Sell |
49,473
-115
| -0.2% | -$12.5K | 1.01% | 40 |
|
|
2013
Q2 | $4.89M | Buy |
+49,588
| New | +$5.15M | 0.91% | 46 |
|
Other funds holding AMGN
VCM
VPM
Lowe Brockenbrough & Co's AMGN Position: Q1 2026 in Review
Lowe Brockenbrough & Co reduced its Amgen (AMGN) stake by 0.94% in Q1 2026, selling an estimated $91.3K and leaving 27,005 shares worth $9.5M. The position accounts for 0.47% of the portfolio, ranked #55.
Lowe Brockenbrough & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.6M in Q2 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Lowe Brockenbrough & Co held 27,005 shares of Amgen worth $9.5M as of Q1 2026.
- Lowe Brockenbrough & Co sold 256 Amgen shares in Q1 2026, an estimated $91.3K.
- Amgen made up 0.47% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #55 holding.
- Lowe Brockenbrough & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Lowe Brockenbrough & Co's Amgen position peaked at $10.6M in Q2 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.